Ranbaxy contests Pfizer mega drug patent in US
Ranbaxy Laboratories has challenged yet another patent of a blockbuster drug in the US market. This will take the company's paragraph IV filings in that country to more than half a dozen. Ranbaxy has
Ranbaxy Laboratories has challenged yet another patent of a blockbuster drug in the US market. This will take the company's paragraph IV filings in that country to more than half a dozen. Ranbaxy has